1 |
Anonymouse (1996). Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet, 347, 1713-27.
DOI
ScienceOn
|
2 |
Althuis MD, Fergenbaum JH, Garcia-Closas M, et al (2004). Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev, 13, 1558-68.
|
3 |
Anothaisintawee T, Teerawattananon Y, Wiratkapun C, et al (2014). Development and validation of a breast cancer risk prediction model for Thai women: a cross-sectional study. Asian Pac J Cancer Prev, 15, 6811-7.
DOI
|
4 |
Ashbeck EL, Rosenberg RD, Stauber PM, et al (2007). Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 16, 467-72.
DOI
|
5 |
Caserta D, Ralli E, Matteucci E, et al (2014). Combined oral contraceptives: health benefits beyond contraception. Panminerva Med, 56, 233-44.
|
6 |
Charlton BM, Rich-Edwards JW, Colditz GA, et al (2014). Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study. BMJ, 349, 6356.
DOI
|
7 |
Chuthapisith S, Permsapaya W, Warnnissorn M, et al (2012). Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev, 13, 459-62.
DOI
ScienceOn
|
8 |
Henderson JT, Sawaya GF, Blum M, et al (2010). Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol, 116, 1257-64.
DOI
|
9 |
Kabat GC, Xue X, Kamensky V, et al (2014). Risk of breast, endometrial, colorectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures. Cancer Causes Control, 26, 219-29.
|
10 |
Kahlenborn C, Modugno F, Potter DM, et al (2006). Oral contraceptive use as a risk factor f or premenopausal breast cancer: a meta-analysis. Mayo Clin Proc, 81, 1290-302.
DOI
|
11 |
Kawai M, Minami Y, Kuriyama S, et al (2010). Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the miyagi cohort study. Cancer Causes Control, 21, 135-45.
DOI
|
12 |
Kitamura K (2014), The proposal for increasing of oral contraceptives use. Acta Obst Gynae Jpn, 9, 2131-41.
|
13 |
Marchbanks PA, McDonald JA, Wilson HG, et al (2002). Oral contraceptives and the risk of breast cancer. N Engl J Med, 346, 2025-32.
DOI
|
14 |
Matsumoto K, Ohkawa Y, Sasauchi K, et al (2003). A survey on low-dose oral contraceptive transactions at pharmacies. Yakugaku Zasshi, 123, 157-162.
DOI
|
15 |
McCormack VA, dos Santos Silva I (2006). Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15, 1159-69.
DOI
|
16 |
Minatoya M, Kutomi G, Shima H, et al (2014). Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study. Asian Pac J Cancer Prev, 15, 8325-30.
DOI
|
17 |
Mori M, Masumori N, Fukuta F, et al (2011). Weight gain and family history of prostate or breast cancers as risk factors for prostate cancer: results of a case-control study in Japan. Asian Pac J Cancer Prev, 12, 743-7.
|
18 |
Nishino Y, Minami Y, Kawai M, et al (2014). Cigarette smoking and breast cancer risk in relation to joint estrogen and progesterone receptor status: a case-control study in Japan. Springerplus, 3, 65.
DOI
|
19 |
Suzuki R, Iwasaki M, Inoue M, et al (2010). Alcohol consumption-associated breast cancer incidence and potential effect modifiers: the Japan Public Health Center-based Prospective Study. Int J Cancer, 127, 685-95.
DOI
|
20 |
Suzuki R, Iwasaki M, Hara A, et al (2013). Fruit and vegetable intake and breast cancer risk defined by estrogen and progesterone receptor status: the Japan public health center-based prospective study. Cancer Causes Control, 24, 2117-28.
DOI
|
21 |
Suzuki R, Iwasaki M, Inoue M, et al (2011). Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status-the Japan public health center-based prospective study. Int J Cancer, 129, 1214-24.
DOI
|
22 |
Telli ML, Chang ET, Kurian AW, et al (2011). Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat, 127, 471-8.
DOI
ScienceOn
|
23 |
Tsakountakis N, Sanidas E, Stathopoulos E, et al (2005). Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status. BMC Womens Health, 5, 1.
DOI
|
24 |
Tsunematsu M, Kawasaki H, Masuoka Y, et al (2013). Factors affecting breast cancer screening behavior in Japanassessment using the health belief model and conjoint analysis. Asian Pac J Cancer Prev, 14, 6041-8.
DOI
ScienceOn
|
25 |
United Nations (2013), World contraceptive patterns 2013. Availableat:http://www.un.org/en/development/desa/population/publications/pdf/family/worldContraceptivePatternsWallChart2013.pdf, accessed October18th, 2014.
|
26 |
Vaisy A, Lotfinejad S, Zhian F (2014). Risk of cancer with combined oral contraceptive use among Iranian women. Asian Pac J Cancer Prev, 15, 5517-22.
DOI
ScienceOn
|
27 |
Wiechmann L, Sampson M, Stempel M, et al (2009). Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol, 16, 2705-10.
DOI
|
28 |
Wada K, Nakamura K, Tamai Y, et al (2013). Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int J Cancer, 133, 952-60.
DOI
|